Article: Tarceva -- erlotinib HCl -- Shows Encouraging Safety Profile and Activity in Phase I Clinical Study in Patients with Malignant Glioma.

Article: Cell Technology commences advanced Phase II-Phase ...
PR Newswire;  July 28, 1988 ;     700+ words ... ... ADVANCED PHASE II/PHASE III BRAIN CANCER CLINICAL TRIALS ... advanced Phase II/Phase III brain cancer trials in multiple ... used in treating brain cancer. The company believes ... advanced Phase II/Phase III clinical trials ...

Article: FDA Gives TransMolecular OK for Phase III ...
BIOWORLD Today;  December 3, 2008 ;     700+ words ... ... with the FDA on the design of a Phase III trial of TM601, a potential treatment ... Temodar, a chemotherapy drug for brain cancer. Study patients would receive ... said in a statement that the Phase III trial would be conducted in patients ...

Article: ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES ...
PR Newswire;  August 15, 2007 ;     700+ words ... ... and final patient in its international phase III trial combining nimotuzumab with radiation ... DIPG). DIPG is an inoperable form of brain cancer for which treatment options are severely limited. The Phase III trial is being conducted by an international ...

Article: Peregrine Pharmaceuticals Announces It has Agreed Upon the Design ...
Business Wire;  December 13, 2001 ;     700+ words ... ... design of a pivotal Phase III study for the treatment ... deadly form of brain cancer, with the company ... aggressive form of brain cancer for which there ... February." The Phase III study will have ... form of primary brain cancer which originates ...

Article: Nova Pharmaceutical announces commencement of Phase ...
PR Newswire;  February 22, 1989 ;     678 words ... ... ANNOUNCES COMMENCEMENT OF PHASE III CLINICAL TESTING FOR NEW BRAIN CANCER TREATMENT BALTIMORE, Feb ... today the commencement of Phase III clinical testing of its BIODEL ... System for the treatment of brain cancer. The BIODEL polymer, which ...

Article: Peregrine Pharmaceuticals Receives FDA Approval for its ...
PR Newswire;  February 24, 2003 ;     700+ words ... ... start its Cotara Phase III registration clinical ... product licensure for brain cancer that should make ... the treatment of brain cancer as well as colorectal ... is a grade four brain cancer that is very aggressive ... dose range for Phase III) the median ...

Article: SUGEN'S PHASE III TRIALS OF DRUG FOR BRAIN ...
BIOWORLD Today;  July 6, 1998 ;     697 words ...Phase III trials are under way with ... randomized, controlled Phase III trial is expected to be ... glioblastoma, a fast-growing brain cancer. SU101 blocks the signaling ... the end of this year and Phase III studies in prostate cancer ...